Despite these uncertain times, we are dedicated to being there for our clients.

Please contact us via e-mail or phone and we can discuss any issues you might have.

Recalls and News / MasterPharm, LLC. Recalls Finasteride Plus 1.25mg for Presence of Undeclared Antihypertensive Drug

Wednesday, May 27, 2020
 drug  fda  finasteride  masterpharm
Share On:

MasterPharm, LLC. Recalls Finasteride Plus 1.25mg for Presence of Undeclared Antihypertensive Drug

MasterPharm, LLC, has recalled a hair loss drug called Finasteride Plus 1.25mg. The warning label on the container provides no warning of the presence of minoxidil found in the capsules.

Minoxidil is an antihypertensive drug that could cause low blood pressure, rapid heartbeat, and retention of water and salt in the body, which causes swelling. These issues could result in heart failure or other heart complications. The amount of minoxidil found in these Finasteride capsules exceeds FDA regulations.

So far, 33 cases have been reported to the FDA. Of course, they can never be sure how many cases may have occurred without being reported.

How to Identify Finasteride Plus

The specific batch of Finasteride Plus has a Beyond Use Date of August 25, 2020. This is a prescription drug. Orange prescription bottles contain 30 capsules, and blue prescription bottles contain 90 capsules. Additionally, MasterPharm, LLC. is attempting to contact its customers and let them know to discontinue use immediately and return the package.

To learn more about this recall, please visit this FDA Safety Recall info page.

If you use Finasteride Plus, please stop using it immediately. If you have experienced any of the symptoms mentioned above or have been seriously injured by this drug, please call Bailey Law today.

Prev:  Daimler Vans Recall: Mercedes-Benz & Freightliner
Next: BIOCELLĀ® Allergan Breast Implants May Cause BIA-ALCL, A Type Of Lymphoma